Cancer Research

EpiCept Corporation To Present At The 2007 BIO InvestorForum

TARRYTOWN, New York, October 4 /PRNewswire/-- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that Jack Talley, President and CEO, will be presenting at the 2007 BIO InvestorForum on October 10, 2007 at 11:45 a.m. local time at ...

Article - Anna Ohlden - Oct 3 2007 - 7:38pm

Hospital Corporation Of America Purchases Seventh CyberKnife(R) System

SUNNYVALE, California, October 4 /PRNewswire/--- Most Recent Purchase for Installation in United Kingdom Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that leading healthcare services company, Hospital ...

Article - Anna Ohlden - Oct 4 2007 - 7:46am

Media Advisory- Oncolytics Biotech Inc. To Present At BIO InvestorForum 2007

CALGARY, Canada, October 4 /PRNewswire/-- Ms. Mary Ann Dillahunty, Vice President, Intellectual Property of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at BIO InvestorForum 2007 on Thursday, October 1 ...

Article - Anna Ohlden - Oct 4 2007 - 12:31pm

Research: Why Is A Pathogen A Pathogen?

That question may be answered as scientists study the recently mapped genetic makeup of a fungus that spawns the worst cereal grains disease known and also can produce toxins potentially fatal to people and livestock. The fungus, which is especially destru ...

Article - News Staff - Oct 5 2007 - 10:42am

Mutations In HMMR Gene Raise Breast Cancer Risk By One Third, Says Study

Researchers in a multicenter international study state that if the HMMR gene becomes mutated it may increase a woman’s risk of breast cancer by more than a third. Further, the researchers found that the gene interacts with the well-known breast cancer gene ...

Article - News Staff - Oct 7 2007 - 3:23pm

EpiCept Announces Successful Completion Of Enrollment For Phase I Trial Of EPC2407

TARRYTOWN, New York, October 8 /PRNewswire/--- Follow up Combination Therapy Trial planned for 2008 EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that it has completed its Phase I clinical trial for EPC2407. The trial has met ...

Article - Anna Ohlden - Oct 7 2007 - 11:06pm

Nationalized Health Care Test Case: Did Medicare Impact Chemotherapy?

Cancer patients receiving chemotherapy have not noticed a restriction in their access to treatment following the enactment of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA), despite the act's significant reduction in g ...

Article - News Staff - Oct 7 2007 - 11:32pm

4SC AG: Patient Treatment In Phase IIa Clinical Trial Completed

PLANEGG-MARTINSRIED, Germany, October 8 /PRNewswire/-- German drug discovery and development company 4SC AG (Frankfurt, Prime Standard), based in Martinsried near Munich, announced today that the last patient was released from the current phase IIa clinic ...

Article - Anna Ohlden - Oct 8 2007 - 2:07am

Thomson Scientific Ranks Australian Universities And Research Institutes

Thomson Scientific today announced the results of a study analyzing Australian institutions' research influence and scientific output. In the September/October issue of Science Watch, Thomson Scientific analyzes data from its Australian University Ind ...

Article - News Staff - Oct 9 2007 - 2:26am

Carolinas HealthCare Selects Ekahau For One Of Nation's Largest Healthcare System RTLS Deployments

RESTON, Virginia, October 9 /PRNewswire/--- Ekahau RTLS Centralizes Asset Management and Enables RTLS Roaming Across Campuses in North Carolina ...

Article - Anna Ohlden - Oct 9 2007 - 5:53am